Director of Research Laboratory
Joining IMBCR in 2019, Stacy brings over 18 years of experience directing in vivo research projects across various investigative areas. Her previous work for The Lundquist Institute involved collaboration with clinicians in the areas of developmental origins of disease and the development of in vivo models for the study of lung cancer treatment. Her current work at IMBCR focuses on the preclinical development and utilization of patient derived xenografts (PDX) for the advancement of multiple myeloma treatment. She holds Bachelor of Science degrees in Biology and Neuroscience from the University of California at Riverside.